Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Exchange Rate Effect (2016 - 2026)

Pharma-Bio Serv's Exchange Rate Effect history spans 17 years, with the latest figure at $9482.0 for Q1 2026.

  • For Q1 2026, Exchange Rate Effect rose 149.68% year-over-year to $9482.0; the TTM value through Jan 2026 reached $73061.0, up 249.54%, while the annual FY2025 figure was $44494.0, 352.38% up from the prior year.
  • Exchange Rate Effect reached $9482.0 in Q1 2026 per PBSV's latest filing, up from $7661.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $90619.0 in Q1 2023 to a low of -$58225.0 in Q4 2023.
  • Average Exchange Rate Effect over 5 years is $3235.0, with a median of -$2500.0 recorded in 2023.
  • Peak YoY movement for Exchange Rate Effect: crashed 568.95% in 2022, then soared 1509.75% in 2023.
  • A 5-year view of Exchange Rate Effect shows it stood at -$21675.0 in 2022, then crashed by 168.63% to -$58225.0 in 2023, then skyrocketed by 95.22% to -$2783.0 in 2024, then soared by 375.28% to $7661.0 in 2025, then grew by 23.77% to $9482.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Exchange Rate Effect are $9482.0 (Q1 2026), $7661.0 (Q4 2025), and $4377.0 (Q3 2025).